+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Protein Engineering Market by Product, Technology, Protein Type, End Use, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717238
The protein engineering market size is estimated to be USD 2,327.4 million in 2022 and is expected to witness a CAGR of 16.87% during the forecast period 2023-2033. Rising demand for protein-based over non-protein therapies and escalating demand for targeted therapies for the treatment of autoimmune and cancer diseases are some of the factors contributing to the market growth. Furthermore, increasing number of government programmes to enhance protein engineering capabilities and surge in prevalence of protein-deficient diseases are other factors supporting the market growth. However, high price of protein engineering techniques and a lack of knowledge in process strategy is expected to hinder the growth.

Increasing number of government programmes to enhance protein engineering capabilities is expected to fuel the market growth during the projected period. For instance, Nabla Bio secured a USD 11 million seed funding round in December 2021, with Zetta Venture Partners and Khosla Ventures serving as the lead investors. With the help of this funding, a protein design platform powered by artificial intelligence (AI) will be developed rapidly, allowing for the fast end-to-end development of new antibody therapeutics.

Surge in prevalence of protein-deficient diseases, including kwashiorkor and marasmus, among people, particularly in developing and underdeveloped countries, is predicted to boost the demand for protein drugs and different treatment options, which is anticipated to increase market growth during the forecast period. For instance, it has been noted that the prevalence of marasmus in the United States is fewer than 5%, according to an article named 'Marasmus' that was published by StatPearls in May 2022. Additionally, adults have a higher probability than children to experience undernutrition in developed countries.

By Product

The market is categorized into software & services, instruments, and reagents. In the global market, the instruments segment accounted for the largest revenue share in 2022 owing to the fact that fast molecular development processes are the preference of researchers for automated technologies. The segment is also expected to expand during the forecast period due to escalating demand for high-efficiency protein engineering tools including real-time PCR equipment and chromatographic systems. The reagents segment is predicted to achieve the fastest CAGR due to the growing use of reagents for a number of applications, such as vaccines, monoclonal antibodies, production of growth factors, and other therapies.

By Technology

The market is divided into directed evolution, rational protein design, de novo protein design, hybrid approach, and others. In 2022, the rational protein design segment accounted for the highest revenue share due to extensive application of the technology in enzyme engineering and antibody development. The production of improved and modified enzymes with the appropriate catalytic characteristics is a result of the significant expansion in the commercial applications of enzyme engineering. The substantial market penetration of such methodologies, which are widely utilised in rational design engineering approaches, helps to drive the segment. The hybrid approach segment is predicted to expand at the fastest rate over the projection period. This is due to the widespread use of hybrid techniques, which combines directed evolution and rational design, for a variety of uses, such as improving redox proteins and enzymes.

By Protein Type

The market is segregated into monoclonal antibodies, insulin, growth factors, colony stimulating factors, coagulation factors, interferon, vaccines, and others. In the global market, the cell & gene therapy segment accounted for the largest revenue share in 2022 owing to increasing R&D expenditure for developing therapeutically improved monoclonal antibodies. The segment is anticipated to grow due to the rising use of targeted monoclonal antibodies for the treatment of cancer and other chronic diseases. Similar to this, the emergence of genetic platforms that employ advanced technology, such as next-generation sequencing for enabling effective protein engineering for the development of monoclonal antibodies, is anticipated to significantly boost the growth potential. The insulin segment is predicted to expand at the fastest CAGR due to the rise in demand for insulin as a result of the increasing number of diabetics around the world.

By End Use

The market is segmented into pharmaceutical & biotechnology companies, academic research institutes, and contract research organizations. In 2022, the pharmaceutical & biotechnology companies segment accounted for the largest revenue share owing to increasing usage of in silico drug research models for the treatment of neurological issues, cancer, and diabetes. Furthermore, the market is being driven by the increasing funding and investment contributions from public and private healthcare organizations for the development of sophisticated protein engineering technologies to improve patient outcomes. The Contract Research Organizations (CROs) segment is predicted to have the fastest CAGR during the forecast period. This can be due to the biopharmaceutical industry's growing inclination for outsourcing, contract research, and production. The segment is expected to be driven by CRO benefits such increased productivity, improved service efficiency, and a focus on important protein engineering development areas such as de novo protein engineering.

Regional Markets

In 2022, North America region accounted for the highest revenue in the protein engineering market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing number of partnerships that major market participants have supported for improving their R&D capabilities. For instance, the Selecta Biosciences, Inc. & Cyrus Biotechnology, Inc. protein engineering collaboration, which launched in September 2021, combines Selecta's ImmTOR platform with Cyrus' ability to fundamentally redesign protein therapies. The primary goal of the partnership was to create an exclusive interleukin-2 (IL-2) agonist that would be used to specifically promote regulatory T cell (Treg) proliferation in patients with autoimmune diseases. The Asia-Pacific region is anticipated to increase at the fastest CAGR throughout the projection period due to the high prevalence of cancer, cardiovascular, and autoimmune disorders in developing Asian nations. Additionally, the rapid economic development in emerging nations such as India and China are anticipated to support the sector's expansion. Furthermore, it is projected that the region's expansion will be aided by the availability of a sizable population base for the research and clinical testing of protein engineering applications.

Competitor Insights

Some of the key players operating in the protein engineering market are Bruker Corp., Inc., Thermo Fisher Scientific, Inc., Genscript Biotech Corp, Bio-Rad Laboratories, PerkinElmer, Merck KGaA, Waters Corp., Danaher Corp., Agilent Technologies, and Amgen Inc.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Creative BioMart improved its protein engineering design and analysis services in August 2022 to help researchers overcome challenges in protein engineering.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, technology, protein, and end use from 2023 to 2033.

Segmentation: Protein Engineering Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Software & Services
  • Instruments
  • Reagents

Technology (Revenue, USD Million), 2022 - 2033

  • Directed Evolution
  • Rational Protein Design
  • De Novo Protein Design
  • Hybrid Approach
  • Others

Protein Type (Revenue, USD Million), 2022 - 2033

  • Monoclonal Antibodies
  • Insulin
  • Growth Factors
  • Colony Stimulating Factors
  • Coagulation Factors
  • Interferon
  • Vaccines
  • Others

End Use (Revenue, USD Million), 2022 - 2033

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Protein Engineering

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Protein Engineering Market

7. Market Analysis by Product
7.1. Software & Services
7.1.1. Software & Services Market Forecast, 2022-2033 (USD Million)
7.2. Instruments
7.2.1. Instruments Market Forecast, 2022-2033 (USD Million)
7.3. Reagents
7.3.1. Reagents Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Technology
8.1. Directed Evolution
8.1.1. Directed Evolution Market Forecast, 2022-2033 (USD Million)
8.2. Rational Protein Design
8.2.1. Rational Protein Design Market Forecast, 2022-2033 (USD Million)
8.3. De Novo Protein Design
8.3.1. De Novo Protein Design Market Forecast, 2022-2033 (USD Million)
8.4. Hybrid Approach
8.4.1. Hybrid Approach Market Forecast, 2022-2033 (USD Million)
8.5. Others
8.5.1. Others Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by Protein Type
9.1. Monoclonal Antibodies
9.1.1. Monoclonal Antibodies Market Forecast, 2022-2033 (USD Million)
9.2. Insulin
9.2.1. Insulin Market Forecast, 2022-2033 (USD Million)
9.3. Growth Factors
9.3.1. Growth Factors Market Forecast, 2022-2033 (USD Million)
9.4. Colony Stimulating Factors
9.4.1. Colony Stimulating Factors Market Forecast, 2022-2033 (USD Million)
9.5. Coagulation Factors
9.5.1. Coagulation Factors Market Forecast, 2022-2033 (USD Million)
9.6. Interferon
9.6.1. Interferon Market Forecast, 2022-2033 (USD Million)
9.7. Vaccines
9.7.1. Vaccines Market Forecast, 2022-2033 (USD Million)
9.8. Others
9.8.1. Others Market Forecast, 2022-2033 (USD Million)

10. Market Analysis by End Use
10.1. Pharmaceutical & Biotechnology Companies
10.1.1. Pharmaceutical & Biotechnology Companies Market Forecast, 2022-2033 (USD Million)
10.2. Academic Research Institutes
10.2.1. Academic Research Institutes Market Forecast, 2022-2033 (USD Million)
10.3. Contract Research Organizations
10.3.1. Contract Research Organizations Market Forecast, 2022-2033 (USD Million)

10. Regional Market Analysis
10.2. Regional Market Trends

11. North America Protein Engineering Market
10.1. North America Protein Engineering Market
10.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
10.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
10.2. U.S. Protein Engineering Market
10.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
10.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
10.3. Canada Protein Engineering Market
10.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
10.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

11. Europe Protein Engineering Market
11.1. Europe Protein Engineering Market
11.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.2. Germany Protein Engineering Market
11.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.3. UK Protein Engineering Market
11.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.4. France Protein Engineering Market
11.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.5. Spain Protein Engineering Market
11.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.6. Italy Protein Engineering Market
11.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.6.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.7. Rest of EuropeProtein Engineering Market
11.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
11.7.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

12. Asia PacificProtein Engineering Market
12.1. Asia PacificProtein Engineering Market
12.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
12.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.2. Japan Protein Engineering Market
12.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
12.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.3. China Protein Engineering Market
12.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
12.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.4. India Protein Engineering Market
12.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
12.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.5. South Korea Protein Engineering Market
12.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
12.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.6. Australia Protein Engineering Market
12.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.6.1.3. Market Size and Forecast by Protein Type 2022-2033 (USD Million)
12.6.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.7. Rest of Asia Pacific Protein Engineering Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
12.7.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
12.7.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

13. Latin America Protein Engineering Market
13.1. Latin America Protein Engineering Market
13.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
13.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.2. BrazilProtein Engineering Market
13.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
13.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.3. MexicoProtein Engineering Market
13.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
13.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.4. Argentina Protein Engineering Market
13.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
13.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.5. Rest of Latin America Protein Engineering Market
13.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
13.5.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
13.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

14. MEAProtein Engineering Market
14.1. MEA Protein Engineering Market
14.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.1.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
14.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.2. GCC Protein Engineering Market
14.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.2.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
14.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.3. South Africa Protein Engineering Market
14.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.3.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
14.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.4. Rest of MEA Protein Engineering Market
14.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Technology, 2022-2033 (USD Million)
14.4.1.3. Market Size and Forecast by Protein Type, 2022-2033 (USD Million)
14.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

15. Competitor Analysis
15.1. Market Share Analysis, 2022
15.2. Major Recent Developments, 2019-2022

16. Company Profiles
16.1. Bruker Corp., Inc.
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Analysis
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Thermo Fisher Scientific, Inc.
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Analysis
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. Genscript Biotech Corp
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Analysis
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. Bio-Rad Laboratories
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Analysis
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. PerkinElmer
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Analysis
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. Merck KGaA
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Analysis
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. Waters Corp.
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Analysis
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. Danaher Corp.
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Analysis
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. Agilent Technologies
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Analysis
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. Amgen Inc.
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Analysis
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Company 11
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Technology Benchmarking
16.11.5. Recent Developments
16.12. Company 12
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Technology Benchmarking
16.12.5. Recent Developments
16.13. Company 13
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Technology Benchmarking
16.13.5. Recent Developments
16.14. Company 14
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Technology Benchmarking
16.14.5. Recent Developments
16.15. Company 15
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Technology Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players

17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bruker Corp. Inc.
  • Thermo Fisher Scientific Inc.
  • Genscript Biotech Corp
  • Bio-Rad Laboratories
  • PerkinElmer
  • Merck KGaA
  • Waters Corp.
  • Danaher Corp.
  • Agilent Technologies
  • Amgen Inc.